晚期腺瘤患者非结直肠癌死亡风险预测模型
该回顾性队列研究纳入2943例切除晚期腺瘤的退伍军人,5年总死亡率16.7%,几乎均为非结直肠癌死亡(16.6%)。
要点
- 晚期腺瘤患者5年死亡几乎均归因于非结直肠癌原因。
- 年龄、合并症负担、特定合并症及近1年住院史与非结直肠癌死亡独立相关。
- 风险评分可分层5年非结直肠癌死亡风险,高分者可能难以从强化监测获益。
核心结论
- 构建的风险预测模型可识别5年内非结直肠癌死亡高风险的晚期腺瘤退伍军人,该人群可能难以从进一步监测中获益。
研究设计与样本
- 回顾性队列研究,纳入2002至2009年间在13个退伍军人医疗中心因诊断或筛查指征行结肠镜且至少有1个晚期腺瘤的≥40岁退伍军人,共2943例。
主要发现
- 队列平均年龄63岁(标准差8.6),98%为男性,74%为白人;5年总死亡率为16.7%,其中非结直肠癌死亡占16.6%。
- 年龄、合并症负担、特定合并症及近1年住院史与非结直肠癌死亡独立相关。
- 按5年非结直肠癌死亡风险分为低(0-1分)、中(2-4分)、高(≥5分)三组,非结直肠癌死亡率分别为6.5%、14.1%和33.2%。
关键数值与推荐
- 风险评分低危组(0-1分)5年非结直肠癌死亡风险为6.5%。
- 风险评分中危组(2-4分)5年非结直肠癌死亡风险为14.1%。
- 风险评分高危组(≥5分)5年非结直肠癌死亡风险为33.2%。
临床怎么用
- 对晚期腺瘤患者可采用该风险评分评估5年非结直肠癌死亡风险,辅助个体化监测决策。
- 高分患者非结直肠癌死亡风险高,强化监测的获益可能有限,应综合评估合并症与预期寿命。
局限性
- 研究为回顾性队列,人群以男性退伍军人为主(98%男性,74%白人),外推需谨慎。
- 模型基于特定人群推导,尚未在外部人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with advanced colorectal adenomas (AAs) are directed to undergo intensive surveillance. However, the benefit derived from surveillance may be outweighed by the risk of death from non-colorectal cancer (CRC) causes, leading to uncertainty on how best to individualize follow-up. The aim of this study was to derive a risk prediction model and risk index that estimate and stratify the risk for non-CRC cancer mortality (NCM) subsequent to diagnosis and removal of AA. METHODS: We conducted a retrospective cohort study of veterans ≥40 years old who had colonoscopy for diagnostic or screening indications at 13 Veterans Affairs Medical Centers between 2002 and 2009 and had 1 or more AAs. The primary outcome was NCM using a fixed follow-up time period of 5 years. Logistic regression using the lasso technique was used to identify factors independently associated with NCM, and an index based on points from regression coefficients was constructed to estimate risk of 5-year NCM. RESULTS: We identified 2943 veterans with AA (mean age [standard deviation] 63 [8.6] years, 98% male, 74% white), with an overall 5-year mortality of 16.7%, which was nearly all due to NCM (16.6%). Age, comorbidity burden, specific comorbid conditions, and hospitalization within the preceding year were independently associated with NCM. The risk prediction model had a goodness of fit (calibration) P value of .41 and c-statistic (discrimination) of 0.74 (95% confidence interval, 0.71-0.76). On the basis of comparable 5-year risks of NCM, the scores comprised 3 risk categories: low (score of 0-1), intermediate (score of 2-4), and high (score of ≥5), in which NCM occurred in 6.5%, 14.1%, and 33.2%, respectively. CONCLUSIONS: We derived a risk prediction model that identifies veterans with advanced adenomas who are at high risk of NCM within 5 years, and who are thus unlikely to benefit from further surveillance.
引用
- Kahi CJ, Myers LJ, Stump TE, et al. Tailoring Surveillance Colonoscopy in Patients With Advanced Adenomas. Clin Gastroenterol Hepatol. 2021. PMID: 33775897. doi:10.1016/j.cgh.2021.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。